Mar 9, 2016 7:00 am EST Preliminary Data Demonstrates 86% Accuracy in Detecting Idiopathic Pulmonary Fibrosis, a Fatal Lung Disease
Feb 17, 2016 7:00 am EST VolitionRx Demonstrates 75% Accuracy in Detecting Highest-Risk Pre-Cancerous Colorectal Adenomas with NuQ® Blood Test
Feb 4, 2016 7:00 am EST VolitionRx and Cancer Survivor Sean Swarner Celebrate World Cancer Day with Message of Hope for Cancer Survival Through Early Detection
Feb 2, 2016 7:00 am EST VolitionRx Initiates Prostate Cancer Study in Collaboration with the Surrey Cancer Research Institute, University of Surrey, UK
Jan 28, 2016 7:00 am EST VolitionRx Receives International ISO Certification for Quality Management System of its NuQ(R) Blood Tests
Jan 5, 2016 7:00 am EST VolitionRx Announces Dr. Jason Terrell's Transition to Full-Time Status as Chief Medical Officer and Head of U.S. Operations
Dec 8, 2015 7:00 am EST VolitionRx Demonstrates More Than 90% Accuracy for Colorectal Cancer NuQ(R) Blood Test in Completed Prospective Study
